Quantification of HIV-1 viral RNA and proviral DNA by isotopic competitive PCR

被引:8
作者
Gratzl, S [1 ]
Moroni, C [1 ]
Hirsch, HH [1 ]
机构
[1] UNIV BASEL,INST MED MICROBIOL,CH-4003 BASEL,SWITZERLAND
关键词
isotopic competitive PCR; HIV-1; viral load; provirus;
D O I
10.1016/S0166-0934(97)00064-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A quantitative isotopic competitive PCR (icPCR) assay was established using P-32-labeled primers targeting the HIV-1 gag gene followed by quantification using a phosphoimager. The detection limit varied from 3 to 10 molecules of DNA and 10 to 100 molecules of RNA per reaction. The icPCR quantification of HIV-1 DNA copies correlated well with the cell number of 8E5/LAV cells bearing a single provirus (r(2) = 0.95). Provirus quantification was applied to overnight infected donor PBMCs, thereby determining infectious virus titres in culture supernatants as a rapid alternative to limiting dilution culture. Parallel quantification of the HIV-1 RNA indicated the infectious virus fraction to be 0.3%. In 39 HIV-l-infected patients with clinical stages A (n = 17), B (n = 15), and C (n = 7), the HIV-1 RNA in the plasma was determined ranging from 100 to 90600 RNA copies/ml. The results of icPCR and a commercial assay (ROCHE Amplicor HIV-I Monitor) correlated well (r = 0.97). In 13 additional patients, the plasma viral load per mi was compared with the proviral load per 10(6) PBMC showing a viral excess of 10-1000-fold (mean of 85, r = 0.7, P < 0.01). It is concluded that icPCR is suitable for the measurement of proviral and viral load in experimental and clinical settings. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:269 / 282
页数:14
相关论文
共 38 条
[1]   DEVELOPMENT OF A RAPID QUANTITATIVE ASSAY FOR HIV-1 PLASMA INFECTIOUS VIREMIA-CULTURE-PCR (CPID) [J].
ARIYOSHI, K ;
BLOOR, S ;
BIENIASZ, PD ;
BOURRELLY, M ;
FOXALL, R ;
WEBER, JN .
JOURNAL OF MEDICAL VIROLOGY, 1994, 43 (01) :28-32
[2]   CLINICAL-EVALUATION OF BRANCHED DNA SIGNAL AMPLIFICATION FOR QUANTIFYING HIV TYPE-1 IN HUMAN PLASMA [J].
CAO, YZ ;
HO, DD ;
TODD, J ;
KOKKA, R ;
URDEA, M ;
LIFSON, JD ;
PIATAK, M ;
CHEN, S ;
HAHN, BH ;
SAAG, MS ;
SHAW, GM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (03) :353-361
[3]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[4]   Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection [J].
Clementi, M ;
Menzo, S ;
Bagnarelli, P ;
Valenza, A ;
Paolucci, S ;
Sampaolesi, R ;
Manzin, A ;
Varaldo, PE .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :135-+
[5]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[6]   DECREASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PLASMA VIREMIA DURING ANTIRETROVIRAL THERAPY REFLECTS DOWN-REGULATION OF VIRAL REPLICATION IN LYMPHOID-TISSUE [J].
COHEN, OJ ;
PANTALEO, G ;
HOLODNIY, M ;
SCHNITMAN, S ;
NIU, M ;
GRAZIOSI, C ;
PAVLAKIS, GN ;
LALEZARI, J ;
BARTLETT, JA ;
STEIGBIGEL, RT ;
COHN, J ;
NOVAK, R ;
MCMAHON, D ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :6017-6021
[7]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[8]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[9]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[10]   BIOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A CLONED LEU-3- CELL SURVIVING INFECTION WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME RETROVIRUS [J].
FOLKS, TM ;
POWELL, D ;
LIGHTFOOTE, M ;
KOENIG, S ;
FAUCI, AS ;
BENN, S ;
RABSON, A ;
DAUGHERTY, D ;
GENDELMAN, HE ;
HOGGAN, MD ;
VENKATESAN, S ;
MARTIN, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :280-290